142 related articles for article (PubMed ID: 4959523)
1. The clinical pharmacology of hexamethylmelamine: Phase I study.
Louis J; Louis NB; Linman JW; Donnelly WJ; Isaacs BL; Schwartz SO
Clin Pharmacol Ther; 1967; 8(1):55-64. PubMed ID: 4959523
[No Abstract] [Full Text] [Related]
2. [Management of anticancer drug adverse reactions].
Akazawa S; Yamashina T; Konuma Y; Takahashi M; Ueno A
Nihon Rinsho; 2001 Apr; 59 Suppl 4():409-14. PubMed ID: 11424416
[No Abstract] [Full Text] [Related]
3. [Complications of antibiotic therapy].
Cah Med; 1971 Dec; 12(17):1527-38. PubMed ID: 5149498
[No Abstract] [Full Text] [Related]
4. [Terminal care. II. Easing of symptoms of cancer patients. 5. Management of adverse effects of antineoplastic agents].
Kurihara M; Matsukawa M; Yamamoto W; Sato A; Cho T; Akazawa S
Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2032-8. PubMed ID: 9036169
[No Abstract] [Full Text] [Related]
5. [Complications of acute leukaemia therapy (author's transl)].
Rubio-Felix D; Raichs A; Torres M; García Zueco JC; Giraldo MP
Sangre (Barc); 1981; 26(5B):919-44. PubMed ID: 7034247
[No Abstract] [Full Text] [Related]
6. Reducing chemotherapy-associated toxicity in elderly cancer patients.
Zagonel V; Fratino L; Sacco C; Babare R; Spazzapan S; Gattei V; Improta S; Pinto A
Cancer Treat Rev; 1996 May; 22(3):223-44. PubMed ID: 8841391
[No Abstract] [Full Text] [Related]
7. [Medical complications of chemotherapy].
Klastersky J
Acta Clin Belg; 1975; 30(6):538-46. PubMed ID: 769462
[No Abstract] [Full Text] [Related]
8. Dose limiting extramedullary toxicity of high dose chemotherapy.
Glode LM
Exp Hematol; 1979; 7 Suppl 5():265-78. PubMed ID: 263244
[TBL] [Abstract][Full Text] [Related]
9. [Lead poisoning].
de Francisci G; Magalini SI
Recenti Prog Med; 1983 Jun; 74(6):687-96. PubMed ID: 6412333
[No Abstract] [Full Text] [Related]
10. [Rheumatology. Side effects of chrysotherapy].
Serre H; Sany J; Rosenberg F
Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):552-9. PubMed ID: 137685
[No Abstract] [Full Text] [Related]
11. The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man.
Schein PS; Davis RD; Carter S; Newman J; Schein DR; Rall DP
Clin Pharmacol Ther; 1970; 11(1):3-40. PubMed ID: 4983384
[No Abstract] [Full Text] [Related]
12. [Side effects of gold salts].
Renier JC; Boasson M
Therapie; 1976; 31(3):365-76. PubMed ID: 136766
[No Abstract] [Full Text] [Related]
13. Adverse effects of antibiotics.
Cunha BA; Ristuccia AM
Heart Lung; 1984 Sep; 13(5):465-72. PubMed ID: 6236175
[No Abstract] [Full Text] [Related]
14. Review of coxib adverse effects notified in France.
Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602396
[No Abstract] [Full Text] [Related]
15. [Preventive and therapeutic measures in cytostatic-associated toxicity].
Cerny T; Buser K; Kiser J; Joss RA
Schweiz Med Wochenschr; 1990 Sep; 120(37):1353-62. PubMed ID: 2218458
[TBL] [Abstract][Full Text] [Related]
16. Prolonged low-dosage administration of hexamethylmelamine (NC 13875).
Wilson WL; Bisel HF; Cole D; Rochlin D; Ramirez G; Madden R
Cancer; 1970 Mar; 25(3):568-70. PubMed ID: 5461337
[No Abstract] [Full Text] [Related]
17. Complications of antibiotic therapy.
Ziment I
Calif Med; 1972 Nov; 117(5):24-48. PubMed ID: 4264289
[TBL] [Abstract][Full Text] [Related]
18. Nursing guidelines and discharge planning for patients receiving recombinant interleukin-2.
Caliendo G; Joyce D; Altmiller MC
Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):25-31. PubMed ID: 8210791
[No Abstract] [Full Text] [Related]
19. A critical review of the literature on carbon disulfide toxicity.
Beauchamp RO; Bus JS; Popp JA; Boreiko CJ; Goldberg L
Crit Rev Toxicol; 1983; 11(3):169-278. PubMed ID: 6349939
[No Abstract] [Full Text] [Related]
20. [Therapeutic diseases].
Lyon Med; 1967 Jun; 217(24):1749-819. PubMed ID: 5607225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
